Skip to content
Back to Blog
June 15, 2026·18 min read

ICD-10-CM Changes 2027: All 238 New and 21 Deleted Codes

238 new codes and 21 deleted, effective October 1, 2026. The complete FY2027 ICD-10-CM list by chapter, plus the cardiomyopathy, arrhythmia, and Z-code changes that affect HCC capture.

ICD-10-CMFY2027Code UpdatesRisk AdjustmentHCC CodingCMS

Reviewed by Jess P., CPC
Reviewed: June 15, 2026

ICD-10-CM Changes 2027: All 238 New and 21 Deleted Codes

The FY2027 ICD-10-CM update adds 238 new codes and removes 21, effective October 1, 2026, per the official CMS FY2027 order file. The additions cluster in injury and poisoning (85), pregnancy and childbirth (56), and musculoskeletal (33). For risk adjustment coders the headline is not the count. It is where they landed: dilated cardiomyopathy, a set of inherited and arrhythmia conditions, and a new block of Z codes that change how history and exposure get captured.

This is the complete, code-by-code list, grouped by ICD-10-CM chapter, plus the deleted codes and the ones that were restructured rather than truly removed. Every code and description comes straight from the official CMS FY2027 files. Bookmark it: when CMS posts the FY2027 risk adjustment mappings, we will add the HCC impact below. For prior-year context, see our FY2026 ICD-10-CM guidelines recap and the April 2026 ICD-10-CM update.

*Source: the official CMS FY2027 ICD-10-CM files (2027 Code Descriptions in Tabular Order), via the CMS ICD-10 page. Effective for encounters October 1, 2026 through September 30, 2027. Counts reflect a direct diff of the FY2027 and FY2026 order files. Verify against the CMS files before relying on any code for billing.*

FY2027 ICD-10-CM changes at a glance, effective October 1, 2026

As of October 1, 2026, ICD-10-CM expands by a net 217 codes. The 238 additions cluster in Chapter 19 (85 codes, mostly toxic-effect expansions for organic solvents, alkenes, and cycloparaffins), Chapter 15 (56 codes, ectopic pregnancy site specificity and vanishing twin detail), Chapter 13 (33 codes, osteomyelitis by site and plantar fasciitis laterality), and Chapter 21 (17 new Z codes for exposure history and gender transition). Twenty-one codes are deleted outright. Beyond those, several previously billable codes were demoted to non-billable category headers, which is the change most likely to slip past a carried-forward code list.

The FY2027 changes that matter most for risk adjustment

What happens to I42.0 dilated cardiomyopathy on October 1, 2026?

Dilated cardiomyopathy is no longer one code. I42.0 stops being billable at the cutover and becomes a category header. You code instead to I42.00 (unspecified), I42.01 (familial-genetic), or I42.09 (other). I42.8 also becomes a header, splitting into I42.81 (arrhythmogenic cardiomyopathy) and I42.89. If your templates or problem lists carry I42.0 or I42.8, they stop validating on October 1. Cardiomyopathy carries risk weight under current models, so confirm the FY2027 HCC assignment for each child code when CMS posts the mapping. For the co-morbidity context, see our heart failure HCC coding guide.

New arrhythmia and inherited cardiac codes

I49.81 (Brugada syndrome), I49.82 (ventricular bigeminy), and I47.22 (catecholaminergic polymorphic ventricular tachycardia) carve out conditions that previously fell to less specific parents. I49.8 itself becomes a non-billable header on October 1. For how arrhythmia specificity affects capture, see our atrial fibrillation HCC coding guide.

Inherited cancer predisposition gets its own block

The new QA1 category adds Lynch syndrome (QA1.71), familial cancer syndrome with BRCA1 (QA1.790) or BRCA2 (QA1.791) mutation, and Li-Fraumeni syndrome (QA1.792). Loeys-Dietz syndrome (Q87.A) and VEXAS syndrome (M04.3) also get first-time discrete codes. These conditions drive screening and surveillance, so the documentation to support them tends to be in the chart.

Gender-related history codes

Z87.8901 through Z87.8909 capture social, medical, surgical, intersex-surgery, and unspecified gender transition history, with Z87.893 for detransition and F64.A for gender identity disorder in remission.

Exposure and history Z codes

Blast overpressure (Z77.40 through Z77.49), Agent Orange (Z77.33), burn pits in a war theater (Z77.32), and gadolinium exposure (Z77.013) paired with R78.72 (abnormal gadolinium level in blood). Z86.17 adds personal history of Clostridioides difficile infection. Z68.18 (BMI 18.4 or less) and Z68.19 (BMI 18.5 to 19.9) add low-end BMI specificity that matters for malnutrition and frailty documentation.

A note on HCC mappings, and why this page will change

Last reviewed June 2026. This section updates as soon as CMS publishes the FY2027 ICD-10 to CMS-HCC crosswalk.

CMS releases the new fiscal year code descriptions first and the risk adjustment crosswalk (ICD-10 to CMS-HCC under V28) later, usually closer to the payment year. As of this writing the FY2027 mappings are not published. We are not going to guess which new codes map to an HCC, because a wrong RAF assumption is worse than no assumption at all. The moment CMS posts the FY2027 mapping, we will add the HCC and RAF impact below and update the date on this page. If you want that mapping the day it drops, the ICD-10 to HCC tool tracks the same cycle. For the model context, see what changed in CMS-HCC V28.

Deleted and restructured FY2027 codes

Most of the 21 deleted codes were restructured, not retired. The sternoclavicular sprain family (S23.420 and its 7th-character siblings) and the organic-solvent toxic-effect family (T52.8X) were broken into more specific codes, which appear in the new-code lists below. Read the full deleted list as a find-and-replace task, not a cleanup. Separately, the billable-to-header demotions noted earlier (I42.0, I42.8, I49.8) are not on this list because the parent still exists, but they stop being codeable. A carried-forward code or a saved favorite is the usual way any of these slip through after October 1.

CodeDescription
S23.420Sprain of sternoclavicular (joint) (ligament)
S23.420ASprain of sternoclavicular (joint) (ligament), initial encounter
S23.420DSprain of sternoclavicular (joint) (ligament), subsequent encounter
S23.420SSprain of sternoclavicular (joint) (ligament), sequela
T52.8XToxic effects of other organic solvents
T52.8X1Toxic effect of other organic solvents, accidental (unintentional)
T52.8X1AToxic effect of other organic solvents, accidental (unintentional), initial encounter
T52.8X1DToxic effect of other organic solvents, accidental (unintentional), subsequent encounter
T52.8X1SToxic effect of other organic solvents, accidental (unintentional), sequela
T52.8X2Toxic effect of other organic solvents, intentional self-harm
T52.8X2AToxic effect of other organic solvents, intentional self-harm, initial encounter
T52.8X2DToxic effect of other organic solvents, intentional self-harm, subsequent encounter
T52.8X2SToxic effect of other organic solvents, intentional self-harm, sequela
T52.8X3Toxic effect of other organic solvents, assault
T52.8X3AToxic effect of other organic solvents, assault, initial encounter
T52.8X3DToxic effect of other organic solvents, assault, subsequent encounter
T52.8X3SToxic effect of other organic solvents, assault, sequela
T52.8X4Toxic effect of other organic solvents, undetermined
T52.8X4AToxic effect of other organic solvents, undetermined, initial encounter
T52.8X4DToxic effect of other organic solvents, undetermined, subsequent encounter
T52.8X4SToxic effect of other organic solvents, undetermined, sequela

Complete list of new FY2027 ICD-10-CM codes

All 238 new codes, grouped by ICD-10-CM chapter. Codes tagged "category header" are non-billable and need an additional character. Always code to the highest level of specificity the record supports. (Source: the CMS FY2027 ICD-10-CM order file, effective October 1, 2026.)

Chapter 2. Neoplasms (3 new)

CodeDescriptionBillable
C78.31Secondary malignant neoplasm of larynxYes
C78.32Secondary malignant neoplasm of pharynxYes
C79.83Secondary malignant neoplasm of oral cavityYes

Chapter 3. Blood & Immune Disorders (2 new)

CodeDescriptionBillable
D69.11Glanzmann thrombastheniaYes
D69.19Other qualitative platelet defectsYes

Chapter 4. Endocrine, Nutritional & Metabolic (3 new)

CodeDescriptionBillable
E89.83Postprocedural hypoglycemia following a procedureNo (header)
E89.830Post bariatric hypoglycemiaYes
E89.838Other postprocedural hypoglycemiaYes

Chapter 5. Mental, Behavioral & Neurodevelopmental (1 new)

CodeDescriptionBillable
F64.AGender identity disorder, in remissionYes

Chapter 9. Circulatory System (9 new)

CodeDescriptionBillable
I42.00Dilated cardiomyopathy, unspecifiedYes
I42.01Familial-genetic dilated cardiomyopathyYes
I42.09Other dilated cardiomyopathyYes
I42.81Arrhythmogenic cardiomyopathyYes
I42.89Other cardiomyopathies not elsewhere classifiedYes
I47.22Catecholaminergic polymorphic ventricular tachycardia [CPVT]Yes
I49.81Brugada syndromeYes
I49.82Ventricular bigeminyYes
I49.89Other specified cardiac arrhythmias not elsewhere classifiedYes

Chapter 10. Respiratory System (7 new)

CodeDescriptionBillable
J34.83Odontogenic sinusitisNo (header)
J34.830Odontogenic sinusitis, maxillary sinusYes
J34.831Odontogenic sinusitis, ethmoid sinusYes
J34.832Odontogenic sinusitis, frontal sinusYes
J34.833Odontogenic sinusitis, sphenoid sinusYes
J34.839Odontogenic sinusitis, unspecifiedYes
J4BPulmonary mycetomaYes

Chapter 11. Digestive System (8 new)

CodeDescriptionBillable
K31.BHypertrophic pyloric stenosis, in childhoodYes
K6ADiseases of the pelvis, not elsewhere classifiedNo (header)
K6A.0Pelvic abscessNo (header)
K6A.01Prevesical abscessYes
K6A.09Other pelvic abscessYes
K6A.8Other diseases of the pelvis, not elsewhere classifiedYes
K74.0AHepatic fibrosis, moderate fibrosisYes
K76.83Intestinal failure-associated liver diseaseYes

Chapter 12. Skin & Subcutaneous Tissue (1 new)

CodeDescriptionBillable
L02.237Carbuncle of flankYes

Chapter 13. Musculoskeletal & Connective Tissue (33 new)

CodeDescriptionBillable
M04.3VEXAS syndromeYes
M67.APlantar fasciitisNo (header)
M67.A0Plantar fasciitis, footNo (header)
M67.A01Plantar fasciitis, right footYes
M67.A02Plantar fasciitis, left footYes
M67.A09Plantar fasciitis, unspecified footYes
M72.20Plantar fascial fibromatosis, unspecified footYes
M72.21Plantar fascial fibromatosis, right footYes
M72.22Plantar fascial fibromatosis, left footYes
M86.8X11Other osteomyelitis, right shoulderYes
M86.8X12Other osteomyelitis, left shoulderYes
M86.8X19Other osteomyelitis, unspecified shoulderYes
M86.8X21Other osteomyelitis, right upper armYes
M86.8X22Other osteomyelitis, left upper armYes
M86.8X29Other osteomyelitis, unspecified upper armYes
M86.8X31Other osteomyelitis, right forearmYes
M86.8X32Other osteomyelitis, left forearmYes
M86.8X39Other osteomyelitis, unspecified forearmYes
M86.8X41Other osteomyelitis, right handYes
M86.8X42Other osteomyelitis, left handYes
M86.8X49Other osteomyelitis, unspecified handYes
M86.8X51Other osteomyelitis, right thighYes
M86.8X52Other osteomyelitis, left thighYes
M86.8X59Other osteomyelitis, unspecified thighYes
M86.8X61Other osteomyelitis, right lower legYes
M86.8X62Other osteomyelitis, left lower legYes
M86.8X69Other osteomyelitis, unspecified lower legYes
M86.8X71Other osteomyelitis, right ankle and footYes
M86.8X72Other osteomyelitis, left ankle and footYes
M86.8X79Other osteomyelitis, unspecified ankle and footYes
M86.8X80Other osteomyelitis, skullYes
M86.8X81Other osteomyelitis, face and sinusesYes
M86.8X89Other osteomyelitis, other siteYes

Chapter 14. Genitourinary System (3 new)

CodeDescriptionBillable
N99.86Intraoperative and postprocedural complications and disorders of breastNo (header)
N99.860Intraoperative and postprocedural nipple ischemiaYes
N99.861Intraoperative and postprocedural nipple necrosisYes

Chapter 15. Pregnancy, Childbirth & the Puerperium (56 new)

Chapter 15 adds 56 codes, mostly ectopic pregnancy site specificity and vanishing twin syndrome detail. Obstetric coding sits outside Medicare Advantage risk adjustment, so these are included for completeness.

CodeDescriptionBillable
O00.12Interstitial ectopic pregnancy without intrauterine pregnancyNo (header)
O00.121Right interstitial ectopic pregnancy without intrauterine pregnancyYes
O00.122Left interstitial ectopic pregnancy without intrauterine pregnancyYes
O00.129Unspecified interstitial ectopic pregnancy without intrauterine pregnancyYes
O00.13Interstitial ectopic pregnancy with intrauterine pregnancyNo (header)
O00.131Right interstitial ectopic pregnancy with intrauterine pregnancyYes
O00.132Left interstitial ectopic pregnancy with intrauterine pregnancyYes
O00.139Unspecified interstitial ectopic pregnancy with intrauterine pregnancyYes
O00.3Cesarean scar ectopic pregnancyNo (header)
O00.31Cesarean scar ectopic pregnancy without intrauterine pregnancyYes
O00.32Cesarean scar ectopic pregnancy with intrauterine pregnancyYes
O00.4Cervical ectopic pregnancyNo (header)
O00.41Cervical ectopic pregnancy without intrauterine pregnancyYes
O00.42Cervical ectopic pregnancy with intrauterine pregnancyYes
O00.5Cornual ectopic pregnancyNo (header)
O00.51Cornual ectopic pregnancy without intrauterine pregnancyNo (header)
O00.511Right cornual ectopic pregnancy without intrauterine pregnancyYes
O00.512Left cornual ectopic pregnancy without intrauterine pregnancyYes
O00.519Unspecified cornual ectopic pregnancy without intrauterine pregnancyYes
O00.52Cornual ectopic pregnancy with intrauterine pregnancyNo (header)
O00.521Right cornual ectopic pregnancy with intrauterine pregnancyYes
O00.522Left cornual ectopic pregnancy with intrauterine pregnancyYes
O00.529Unspecified cornual ectopic pregnancy with intrauterine pregnancyYes
O31.4Continuing pregnancy after vanishing twin syndrome of one fetus or moreNo (header)
O31.40Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimesterNo (header)
O31.40X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, not applicable or unspecifiedYes
O31.40X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 1Yes
O31.40X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 2Yes
O31.40X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 3Yes
O31.40X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 4Yes
O31.40X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 5Yes
O31.40X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, other fetusYes
O31.41Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimesterNo (header)
O31.41X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, not applicable or unspecifiedYes
O31.41X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 1Yes
O31.41X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 2Yes
O31.41X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 3Yes
O31.41X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 4Yes
O31.41X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 5Yes
O31.41X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, other fetusYes
O31.42Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimesterNo (header)
O31.42X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, not applicable or unspecifiedYes
O31.42X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 1Yes
O31.42X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 2Yes
O31.42X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 3Yes
O31.42X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 4Yes
O31.42X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 5Yes
O31.42X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, other fetusYes
O31.43Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimesterNo (header)
O31.43X0Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, not applicable or unspecifiedYes
O31.43X1Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 1Yes
O31.43X2Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 2Yes
O31.43X3Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 3Yes
O31.43X4Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 4Yes
O31.43X5Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 5Yes
O31.43X9Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, other fetusYes

Chapter 17. Congenital Malformations (9 new)

CodeDescriptionBillable
Q87.ALoeys-Dietz syndromeYes
QA1Genetic disorders associated with neoplasms, not elsewhere classifiedNo (header)
QA1.7Inherited neoplasm predisposition syndromes involving multiple systems, not elsewhere classifiedNo (header)
QA1.71Lynch syndromeYes
QA1.79Other inherited neoplasm predisposition syndrome of multiple systemsNo (header)
QA1.790Familial cancer syndrome with pathogenic BRCA1 mutationYes
QA1.791Familial cancer syndrome with pathogenic BRCA2 mutationYes
QA1.792Li Fraumeni syndromeYes
QA1.798Other inherited neoplasm predisposition syndrome of multiple systemsYes

Chapter 18. Symptoms, Signs & Abnormal Findings (1 new)

CodeDescriptionBillable
R78.72Abnormal gadolinium level in bloodYes

Chapter 19. Injury, Poisoning & External Causes (85 new)

Chapter 19 holds 85 of the 238 additions, almost entirely toxic-effect codes split from the deleted T52.8X family (alkenes, cycloparaffins, hexamethylene diisocyanate, and medetomidine). These are low-relevance for most risk adjustment work and are listed here for completeness.

CodeDescriptionBillable
T52.81Toxic effects of alkenesNo (header)
T52.811Toxic effect of alkenes, accidental (unintentional)No (header)
T52.811AToxic effect of alkenes, accidental (unintentional), initial encounterYes
T52.811DToxic effect of alkenes, accidental (unintentional), subsequent encounterYes
T52.811SToxic effect of alkenes, accidental (unintentional), sequelaYes
T52.812Toxic effect of alkenes, intentional self-harmNo (header)
T52.812AToxic effect of alkenes, intentional self-harm, initial encounterYes
T52.812DToxic effect of alkenes, intentional self-harm, subsequent encounterYes
T52.812SToxic effect of alkenes, intentional self-harm, sequelaYes
T52.813Toxic effect of alkenes, assaultNo (header)
T52.813AToxic effect of alkenes, assault, initial encounterYes
T52.813DToxic effect of alkenes, assault, subsequent encounterYes
T52.813SToxic effect of alkenes, assault, sequelaYes
T52.814Toxic effect of alkenes, undeterminedNo (header)
T52.814AToxic effect of alkenes, undetermined, initial encounterYes
T52.814DToxic effect of alkenes, undetermined, subsequent encounterYes
T52.814SToxic effect of alkenes, undetermined, sequelaYes
T52.82Toxic effects of cycloparaffinsNo (header)
T52.821Toxic effect of cycloparaffins, accidental (unintentional)No (header)
T52.821AToxic effect of cycloparaffins, accidental (unintentional), initial encounterYes
T52.821DToxic effect of cycloparaffins, accidental (unintentional), subsequent encounterYes
T52.821SToxic effect of cycloparaffins, accidental (unintentional), sequelaYes
T52.822Toxic effect of cycloparaffins, intentional self-harmNo (header)
T52.822AToxic effect of cycloparaffins, intentional self-harm, initial encounterYes
T52.822DToxic effect of cycloparaffins, intentional self-harm, subsequent encounterYes
T52.822SToxic effect of cycloparaffins, intentional self-harm, sequelaYes
T52.823Toxic effect of cycloparaffins, assaultNo (header)
T52.823AToxic effect of cycloparaffins, assault, initial encounterYes
T52.823DToxic effect of cycloparaffins, assault, subsequent encounterYes
T52.823SToxic effect of cycloparaffins, assault, sequelaYes
T52.824Toxic effect of cycloparaffins, undeterminedNo (header)
T52.824AToxic effect of cycloparaffins, undetermined, initial encounterYes
T52.824DToxic effect of cycloparaffins, undetermined, subsequent encounterYes
T52.824SToxic effect of cycloparaffins, undetermined, sequelaYes
T52.89Toxic effects of other organic solventsNo (header)
T52.891Toxic effect of other organic solvents, accidental (unintentional)No (header)
T52.891AToxic effect of other organic solvents, accidental (unintentional), initial encounterYes
T52.891DToxic effect of other organic solvents, accidental (unintentional), subsequent encounterYes
T52.891SToxic effect of other organic solvents, accidental (unintentional), sequelaYes
T52.892Toxic effect of other organic solvents, intentional self-harmNo (header)
T52.892AToxic effect of other organic solvents, intentional self-harm, initial encounterYes
T52.892DToxic effect of other organic solvents, intentional self-harm, subsequent encounterYes
T52.892SToxic effect of other organic solvents, intentional self-harm, sequelaYes
T52.893Toxic effect of other organic solvents, assaultNo (header)
T52.893AToxic effect of other organic solvents, assault, initial encounterYes
T52.893DToxic effect of other organic solvents, assault, subsequent encounterYes
T52.893SToxic effect of other organic solvents, assault, sequelaYes
T52.894Toxic effect of other organic solvents, undeterminedNo (header)
T52.894AToxic effect of other organic solvents, undetermined, initial encounterYes
T52.894DToxic effect of other organic solvents, undetermined, subsequent encounterYes
T52.894SToxic effect of other organic solvents, undetermined, sequelaYes
T59.82Toxic effects of hexamethylene diisocyanateNo (header)
T59.821Toxic effect of hexamethylene diisocyanate, accidental (unintentional)No (header)
T59.821AToxic effect of hexamethylene diisocyanate, accidental (unintentional), initial encounterYes
T59.821DToxic effect of hexamethylene diisocyanate, accidental (unintentional), subsequent encounterYes
T59.821SToxic effect of hexamethylene diisocyanate, accidental (unintentional), sequelaYes
T59.822Toxic effect of hexamethylene diisocyanate, intentional self-harmNo (header)
T59.822AToxic effect of hexamethylene diisocyanate, intentional self-harm, initial encounterYes
T59.822DToxic effect of hexamethylene diisocyanate, intentional self-harm, subsequent encounterYes
T59.822SToxic effect of hexamethylene diisocyanate, intentional self-harm, sequelaYes
T59.823Toxic effect of hexamethylene diisocyanate, assaultNo (header)
T59.823AToxic effect of hexamethylene diisocyanate, assault, initial encounterYes
T59.823DToxic effect of hexamethylene diisocyanate, assault, subsequent encounterYes
T59.823SToxic effect of hexamethylene diisocyanate, assault, sequelaYes
T59.824Toxic effect of hexamethylene diisocyanate, undeterminedNo (header)
T59.824AToxic effect of hexamethylene diisocyanate, undetermined, initial encounterYes
T59.824DToxic effect of hexamethylene diisocyanate, undetermined, subsequent encounterYes
T59.824SToxic effect of hexamethylene diisocyanate, undetermined, sequelaYes
T65.85Toxic effect of medetomidineNo (header)
T65.851Toxic effect of medetomidine, accidental (unintentional)No (header)
T65.851AToxic effect of medetomidine, accidental (unintentional), initial encounterYes
T65.851DToxic effect of medetomidine, accidental (unintentional), subsequent encounterYes
T65.851SToxic effect of medetomidine, accidental (unintentional), sequelaYes
T65.852Toxic effect of medetomidine, intentional self-harmNo (header)
T65.852AToxic effect of medetomidine, intentional self-harm, initial encounterYes
T65.852DToxic effect of medetomidine, intentional self-harm, subsequent encounterYes
T65.852SToxic effect of medetomidine, intentional self-harm, sequelaYes
T65.853Toxic effect of medetomidine, assaultNo (header)
T65.853AToxic effect of medetomidine, assault, initial encounterYes
T65.853DToxic effect of medetomidine, assault, subsequent encounterYes
T65.853SToxic effect of medetomidine, assault, sequelaYes
T65.854Toxic effect of medetomidine, undeterminedNo (header)
T65.854AToxic effect of medetomidine, undetermined, initial encounterYes
T65.854DToxic effect of medetomidine, undetermined, subsequent encounterYes
T65.854SToxic effect of medetomidine, undetermined, sequelaYes

Chapter 21. Factors Influencing Health Status (Z codes) (17 new)

CodeDescriptionBillable
Z68.18Body mass index [BMI] 18.4 or less, adultYes
Z68.19Body mass index [BMI] 18.5-19.9, adultYes
Z77.013Contact with and (suspected) exposure to gadoliniumYes
Z77.32Contact with and (suspected) exposure to burn pits in war theaterYes
Z77.33Contact with and (suspected) exposure to Agent OrangeYes
Z77.4Contact with and (suspected) exposure to blast overpressureNo (header)
Z77.40Contact with and (suspected) exposure to unspecified blast overpressureYes
Z77.41Contact with and (suspected) exposure to low-level blast overpressureYes
Z77.42Contact with and (suspected) exposure to high-level blast overpressureYes
Z77.49Contact with and (suspected) exposure to other blast overpressureYes
Z86.17Personal history of Clostridioides difficile infectionYes
Z87.8901Personal history of social gender transitionYes
Z87.8902Personal history of medical gender transitionYes
Z87.8903Personal history of surgical gender transitionYes
Z87.8904Personal history of intersex surgeryYes
Z87.8909Personal history of unspecified gender transitionYes
Z87.893Personal history of gender detransitionYes

How should coders prepare for the FY2027 cutover?

  • Audit your top codes. Pull your most-captured codes and check them against the deleted and demoted lists. Replace I42.0, I42.8, I49.8, S23.420, and T52.8X favorites now, not in October.
  • Update templates and pick lists. Fix encounter templates, problem-list pick lists, and superbills before the cutover, not after.
  • Flag the new specificity. Queue documentation queries for cardiomyopathy type, arrhythmia type, low BMI, exposure history, and inherited syndromes so the detail is in the note.
  • Hold the RAF math. Do not assume an HCC or RAF value on any new code until CMS publishes the FY2027 mapping.
  • Re-run a sample. Test a batch of recent charts against the FY2027 set to see where your specificity has to change.
  • The codes are final. The risk adjustment mapping is the piece still to come, and we will update this page the day it lands.

    Jess P., CPC

    Jess P., CPC

    Certified Professional Coder

    Jess reviews HCC Buddy editorial content for accuracy against the current CMS-HCC model and the active FY ICD-10-CM tabular release.

    Get HCC Coding Tips in Your Inbox

    Join our newsletter for coding tips, guideline updates, and tool announcements.

    Related Articles